Concepedia

Peter Burdon

PB

Statistics

Publications

2

Citations

54

H-Index

2

Active since

2018

Affiliations

Amgen (Switzerland)(Current)

Amgen (United Kingdom)

Peter Burdon is an author at Amgen (Switzerland) specializing in cancer research, medicine, and dermatology.

ORCID

Top concepts

Publications per year

2018–2020

2

Publications

2

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials

Marc Peeters, Timothy Price, Fernando Rivera et al. · British Journal of Cancer · 2018 · 37 citations · Full text

Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers

George Kafatos, Sabada Dube, Peter Burdon et al. · Clinical Colorectal Cancer · 2020 · 17 citations

, , +9

1–2 of 2